📊 PBH Key Takeaways
Is Prestige Consumer Healthcare Inc. (PBH) a Good Investment?
Prestige Consumer Healthcare demonstrates strong operational fundamentals with 28.4% operating margins, excellent liquidity (3.57x current ratio), and robust free cash flow generation ($246.4M). However, the 2671% revenue surge coupled with 11.3% net income decline and 8.9% EPS decline signals poor acquisition quality or severe integration challenges that undermine earnings durability.
Prestige Consumer Healthcare Inc. Key Strengths (PBH)
- Exceptional operating margin (28.4%) and net margin (17.5%) with strong FCF generation ($246.4M, 22.6% FCF margin)
- Fortress-like balance sheet: 3.57x current ratio, 171.9x interest coverage, and moderate 0.53x debt/equity leverage
- Established pharma/OTC consumer healthcare business model with stable, recurring revenue characteristics
PBH Stock Risks: Prestige Consumer Healthcare Inc. Investment Risks
- Net income declining 11.3% YoY despite extraordinary 2671% revenue growth indicates poor acquisition accretion or massive integration costs eroding profitability
- EPS down 8.9% despite revenue surge reflects shareholder dilution and rising cost structure threatening earnings sustainability
- Critically low cash position ($63.9M) against $994M debt creates refinancing vulnerability if operating cash flow deteriorates
Key Metrics to Watch
- Normalized net income and EPS trajectory post-acquisition - must show stabilization and growth to validate deal quality
- Operating cash flow sustainability and free cash flow generation - any decline below $200M annually signals distress
- Debt reduction progress and cash position growth - critical to reduce leverage given liquidity constraints
Prestige Consumer Healthcare Inc. (PBH) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The 22.6% free cash flow margin provides substantial flexibility for dividends, buybacks, and strategic investments. Strong liquidity with a 3.57x current ratio provides a solid financial cushion.
PBH Profit Margin, ROE & Profitability Analysis
PBH vs Healthcare Sector: How Prestige Consumer Healthcare Inc. Compares
How Prestige Consumer Healthcare Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Prestige Consumer Healthcare Inc. Stock Overvalued? PBH Valuation Analysis 2026
Based on fundamental analysis, Prestige Consumer Healthcare Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Prestige Consumer Healthcare Inc. Balance Sheet: PBH Debt, Cash & Liquidity
PBH Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Prestige Consumer Healthcare Inc.'s revenue has shown modest growth of 5% over the 5-year period. The most recent EPS of $4.17 reflects profitable operations.
PBH Revenue Growth, EPS Growth & YoY Performance
PBH Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2026 | $283.4M | $46.7M | $0.97 |
| Q2 2026 | $274.1M | $42.2M | $0.86 |
| Q1 2026 | $249.5M | $47.5M | $0.95 |
| Q3 2025 | $282.7M | $53.0M | $1.06 |
| Q2 2025 | $283.8M | $53.6M | $1.07 |
| Q1 2025 | $267.1M | $49.1M | $0.98 |
| Q3 2024 | $275.5M | $52.0M | $1.04 |
| Q2 2024 | $286.3M | $51.0M | $1.02 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Prestige Consumer Healthcare Inc. Dividends, Buybacks & Capital Allocation
PBH SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Prestige Consumer Healthcare Inc. (CIK: 0001295947)
📋 Recent SEC Filings
❓ Frequently Asked Questions about PBH
What is the AI rating for PBH?
Prestige Consumer Healthcare Inc. (PBH) has an AI grade of B with 68% confidence, based on fundamental analysis of SEC EDGAR filings.
What are PBH's key strengths?
Claude: Exceptional operating margin (28.4%) and net margin (17.5%) with strong FCF generation ($246.4M, 22.6% FCF margin). Fortress-like balance sheet: 3.57x current ratio, 171.9x interest coverage, and moderate 0.53x debt/equity leverage.
What are the risks of investing in PBH?
Claude: Net income declining 11.3% YoY despite extraordinary 2671% revenue growth indicates poor acquisition accretion or massive integration costs eroding profitability. EPS down 8.9% despite revenue surge reflects shareholder dilution and rising cost structure threatening earnings sustainability.
What is PBH's revenue and growth?
Prestige Consumer Healthcare Inc. reported revenue of $1.1B.
Does PBH pay dividends?
Prestige Consumer Healthcare Inc. does not currently pay dividends.
Where can I find PBH SEC filings?
Official SEC filings for Prestige Consumer Healthcare Inc. (CIK: 0001295947) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is PBH's EPS?
Prestige Consumer Healthcare Inc. has a diluted EPS of $3.91.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is PBH's fundamental grade?
Based on our AI fundamental analysis in May 2026, Prestige Consumer Healthcare Inc. has a B grade with 68% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is PBH stock overvalued or undervalued?
Valuation metrics for PBH: ROE of 10.1% (sector avg: 15%), net margin of 17.5% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is PBH's AI grade for 2026?
Our dual AI analysis gives Prestige Consumer Healthcare Inc. a combined B grade for 2026. Revenue is data pending, with profitability above sector average. Always conduct your own research.
What is PBH's free cash flow?
Prestige Consumer Healthcare Inc.'s operating cash flow is $257.6M, with capital expenditures of $11.2M. FCF margin is 22.6%.
How does PBH compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin 17.5% (avg: 12%), ROE 10.1% (avg: 15%), current ratio 3.57 (avg: 2).